263 related articles for article (PubMed ID: 31134766)
1. AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction.
Landolt L; Furriol J; Babickova J; Ahmed L; Eikrem Ø; Skogstrand T; Scherer A; Suliman S; Leh S; Lorens JB; Gausdal G; Marti HP; Osman T
Physiol Rep; 2019 May; 7(10):e14091. PubMed ID: 31134766
[TBL] [Abstract][Full Text] [Related]
2. Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model.
Hoel A; Osman T; Hoel F; Elsaid H; Chen T; Landolt L; Babickova J; Tronstad KJ; Lorens JB; Gausdal G; Marti HP; Furriol J
J Cell Mol Med; 2021 Aug; 25(15):7407-7417. PubMed ID: 34219376
[TBL] [Abstract][Full Text] [Related]
3. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
4. The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring.
Tang PM; Zhou S; Li CJ; Liao J; Xiao J; Wang QM; Lian GY; Li J; Huang XR; To KF; Ng CF; Chong CC; Ma RC; Lee TL; Lan HY
Kidney Int; 2018 Jan; 93(1):173-187. PubMed ID: 29042082
[TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation.
Bijkerk R; Aleksinskaya MA; Duijs JMGJ; Veth J; Husen B; Reiche D; Prehn C; Adamski J; Rabelink TJ; De Mey JGR; van Zonneveld AJ
Clin Sci (Lond); 2019 Jan; 133(2):239-252. PubMed ID: 30617188
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
Grøndal SM; Tutusaus A; Boix L; Reig M; Blø M; Hodneland L; Gausdal G; Jackson A; Garcia de Frutos P; Lorens JB; Morales A; Marí M
Front Immunol; 2024; 15():1400553. PubMed ID: 38817615
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Ciardiello D; Blauensteiner B; Matrone N; Belli V; Mohr T; Vitiello PP; Martini G; Poliero L; Cardone C; Napolitano S; De Falco V; Giunta EF; Ciaramella V; Corte CD; Barra G; Selvaggi F; Franco R; Marino FZ; Cuomo A; Morgillo F; Troiani T; Sibilia M; Ciardiello F; Martinelli E
Med Oncol; 2021 Feb; 38(3):24. PubMed ID: 33570712
[TBL] [Abstract][Full Text] [Related]
8. AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
Chen TJ; Mydel P; Benedyk-Machaczka M; Kamińska M; Kalucka U; Blø M; Furriol J; Gausdal G; Lorens J; Osman T; Marti HP
Physiol Rep; 2021 Dec; 9(23):e15140. PubMed ID: 34877810
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
10. Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.
Cui W; Maimaitiyiming H; Qi X; Norman H; Zhou Q; Wang X; Fu J; Wang S
Am J Physiol Renal Physiol; 2014 May; 306(9):F996-1007. PubMed ID: 24573388
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer.
Danielli SG; Wurth J; Morice S; Kisele S; Surdez D; Delattre O; Bode PK; Wachtel M; Schäfer BW
Mol Cancer Ther; 2024 Jun; 23(6):864-876. PubMed ID: 38471796
[TBL] [Abstract][Full Text] [Related]
12. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
[TBL] [Abstract][Full Text] [Related]
13. AXL Is a Potential Target for the Treatment of Intestinal Fibrosis.
Steiner CA; Rodansky ES; Johnson LA; Berinstein JA; Cushing KC; Huang S; Spence JR; Higgins PDR
Inflamm Bowel Dis; 2021 Feb; 27(3):303-316. PubMed ID: 32676663
[TBL] [Abstract][Full Text] [Related]
14. Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner.
Zdżalik-Bielecka D; Kozik K; Poświata A; Jastrzębski K; Jakubik M; Miączyńska M
Mol Cancer Res; 2022 Mar; 20(3):446-455. PubMed ID: 34782372
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.
Palisoul ML; Quinn JM; Schepers E; Hagemann IS; Guo L; Reger K; Hagemann AR; McCourt CK; Thaker PH; Powell MA; Mutch DG; Fuh KC
Mol Cancer Ther; 2017 Dec; 16(12):2881-2891. PubMed ID: 28904132
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis.
Zhen Y; Lee IJ; Finkelman FD; Shao WH
J Autoimmun; 2018 Sep; 93():37-44. PubMed ID: 29895432
[TBL] [Abstract][Full Text] [Related]
17. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
[TBL] [Abstract][Full Text] [Related]
18. [A Study on the Role and Mechanism of Fenofibrate in Mice Renal Fibrosis Induced by Unilateral Ureteral Obstruction].
Xu SS; Li S; Zhang XX; Qi JZ; Li GY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):670-674. PubMed ID: 32975082
[TBL] [Abstract][Full Text] [Related]
19. Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling.
Choi SY; Piao ZH; Jin L; Kim JH; Kim GR; Ryu Y; Lin MQ; Kim HS; Kee HJ; Jeong MH
PLoS One; 2016; 11(11):e0167340. PubMed ID: 27902771
[TBL] [Abstract][Full Text] [Related]
20. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
Giles KM; Kalinowski FC; Candy PA; Epis MR; Zhang PM; Redfern AD; Stuart LM; Goodall GJ; Leedman PJ
Mol Cancer Ther; 2013 Nov; 12(11):2541-58. PubMed ID: 24026012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
